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Abstract
Clostridium difficile is the most common cause of antibiotic-associated nosocomial infection in the United States. C. difficile
secretes two homologous toxins, TcdA and TcdB, which are responsible for the symptoms of C. difficile associated disease.
The mechanism of toxin action includes an autoprocessing event where a cysteine protease domain (CPD) releases a
glucosyltransferase domain (GTD) into the cytosol. The GTD acts to modify and inactivate Rho-family GTPases. The
presumed importance of autoprocessing in toxicity, and the apparent specificity of the CPD active site make it, potentially,
an attractive target for small molecule drug discovery. In the course of exploring this potential, we have discovered that
both wild-type TcdB and TcdB mutants with impaired autoprocessing or glucosyltransferase activities are able to induce
rapid, necrotic cell death in HeLa and Caco-2 epithelial cell lines. The concentrations required to induce this phenotype
correlate with pathology in a porcine colonic explant model of epithelial damage. We conclude that autoprocessing and
GTD release is not required for epithelial cell necrosis and that targeting the autoprocessing activity of TcdB for the
development of novel therapeutics will not prevent the colonic tissue damage that occurs in C. difficile – associated disease.
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Introduction
Clostridium difficile is a gram-positive, spore-forming anaerobe
that infects the colon and causes a range of gastrointestinal
disorders including diarrhea, pseudomembranous colitis, and toxic
megacolon [1,2]. This is a major healthcare concern as the
number and severity of C. difficile-associated disease (CDAD) cases
have increased dramatically in recent years [3]. Two large toxins,
TcdA and TcdB (308 kDa and 270 kDa, respectively), are
recognized as the main virulence factors of C. difficile [4,5]. The
C-terminal portion of these toxins is responsible for delivering an
N-terminal glucosyltransferase domain (GTD) into the host cell
[6,7]. The GTD inactivates Rho family GTPases including Rho,
Rac1, and Cdc42 [8,9].
While there are numerous studies that report the effects of
toxin-mediated glucosylation in cells, a consensus as to the
conclusion of these reports, taken together, has been difficult due
to differences in cell types, toxin concentrations, and assay
methods. In addition, it appears that TcdA and TcdB can elicit
different effects under similar conditions [10,11]. In all reports,
both toxins can induce a cytopathic effect characterized by cell
rounding. In many reports, these cells go on to die by apoptotic
mechanisms, but the time course can be up to 48 hours [12–19]. It
has been noted, however, that apoptosis cannot be detected in cells
treated with higher concentrations of TcdB [20]. In at least one
study, the absence of apoptosis in cells treated with TcdB has led
to suggestions of a necrotic mechanism of cell death [21].
The mechanism of GTD delivery for TcdA and TcdB involves
binding a host cell receptor [22,23], uptake by endocytosis [24,25],
pH-dependent pore formation [26–28], translocation across the
endosomal membrane, host-factor dependent autoprocessing [29],
and release of the GTD into the host cell cytosol [30]. Release is
thought to allow the GTD access to the Rho-family GTPases
tethered to the plasma membrane surface. An N-terminal sub-
domain within the GTD is thought to serve as a membrane
localization domain [31].
The autoprocessing function of the toxins is mediated by a
cysteine protease domain (CPD) that follows the N-terminal GTD
[32]. Inositolphosphates, predominantly inositol hexakisphosphate
(InsP6), have been identified as the host factors responsible for
inducing autoprocessing [29]. The InsP6-bound structures of the
TcdA and TcdB CPDs reveal a positively charged InsP6-binding
pocket that is distinct from the catalytic active site [33,34]. InsP6
binding is thought to trigger conformational changes that permit
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the formation of the substrate-binding pocket and alignment of the
catalytic residues [35]. The three catalytic amino acids Asp587,
His653, and Cys698 (TcdB sequence) and the P1 substrate
recognition site, Leu543, have been shown to be important for in
vitro processing activity by genetic mutation [32]. Mutation and
chemical modification of these residues has also been shown to
prevent activity in various cell based assays [29,32,34,36,37]. For
this reason, TcdB autoprocessing activity and GTD release have
been considered important in the toxin mechanism, an idea which
suggests that the CPD could serve as a useful target for novel small
molecule inhibitor discovery.
The objective at the outset of this project was to conduct a high-
throughput screen for small molecules that inhibit TcdB-mediated
cell death. Our first step toward exploring this potential was to
evaluate apoptotic and necrotic markers as cell death indicators. In
observing a necrotic response to TcdB, we decided to specifically
focus on the question of whether the assay would be able to detect
inhibition of TcdB autoprocessing. We constructed mutant TcdB
proteins with deficiencies in either the autoprocessing or glucosyl-
transferase activities and tested their effects on cell viability. Our
unexpected observation that the mutants killed cells rapidly and at
concentrations comparable to wild-type led us to investigate the
role of autoprocessing and GTD release in cell death and cell
rounding in greater detail. In this report, we provide evidence that
epithelial cells and porcine colonic tissue challenged with TcdB
undergo a rapid, necrotic cell death that is not dependent on
autoprocessing and GTD release.
Results
TcdB induces necrosis in cultured epithelial cells
The objective at the outset of this project was to conduct a high-
throughput screen for small molecules that inhibit TcdB-mediated
cell death. Our first goal was, therefore, to establish conditions for
an assay that was sensitive and homogeneous. HeLa cells were
seeded into 384 well plates and treated with TcdB at multiple
concentrations for varying lengths of time. Cells were then
simultaneously assayed for caspase-3/7 activation and ATP levels
using fluorescent and luminescent indicators, respectively. At all
concentrations and time points tested, TcdB failed to activate
caspase-3 and -7, central regulators in apoptotic cell death
(Figure 1A). Conversely, staurosporine, a known inducer of
apoptosis, triggered significant caspase-3/7 activation at a 5 hour
time point. Since the result appeared to be in conflict with a
previous report showing that TcdB-treatment of HeLa cells
induced an increased rate of caspase-3 activity [18], we performed
additional experiments using lower toxin concentrations, a
48 hour time point, and TcdA. We did not observe caspase-3/7
activation in any of the cells treated with TcdB and only saw
TcdA-induced caspase-3/7 activation when the toxin was applied
at concentrations of 100 nM (Figure S1A). While our initial
experiments were performed with TcdB purified from a recom-
binant Bacillus megaterium expression system, we did not observe
caspase-3/7 activation when we tested TcdB purified from C.
difficile culture supernatants (Figure S1B).
Despite the lack of caspase-3/7 activation, the TcdB
treatments had a significant impact on cellular ATP levels
(Figure 1B). Decreases in ATP were observed after only
2.5 hours in cells treated with 1, 10, and 100 nM TcdB
suggesting that these cells were no longer viable. The effect is
specific to TcdB, as TcdA only impacted the viability at
concentrations of 100 nM at 24 hours (Figure S2A). While lower
concentrations of TcdB can induce cell death after a 48 hour
application, the effect does not appear to be dose dependent at
the 48 hour time point (Figure S2A).
In an attempt to correlate the viability indicators with
cytopathic events, mock and TcdB treated cells were visualized
by light microscopy. At concentrations of 10 pM, a characteristic
cytopathic (cell rounding) effect was observed. In contrast, cells
treated with 10 nM TcdB for 2.5 hours had completely lost their
membrane integrity (Figure 1C). The rapid loss of ATP and
membrane integrity suggested that cells treated with nM
concentrations of TcdB were dying by necrosis. To further test
this hypothesis, we assessed the effect of TcdB on LDH and
HMGB1 release. LDH release was apparent 2.5 hours after
intoxication and at an increased level after 8 hours (Figure 1D).
Similar values for LDH release are observed when the cells are
treated with TcdB from C. difficile supernatants (Figure S2B).
Notably, LDH release is only detectable at toxin concentrations
above 0.1 nM, consistent with the cell death data obtained with an
ATP indicator (Figure 1B). HMGB1 is a nuclear protein that is
released into the cytoplasm when the cell is dying by necrosis. We
found that at 10 nM TcdB, HMGB1 was released into the
cytoplasm after 1 hour (Figure 1E). As a result of these studies,
CellTiterGlo, the luminescent indicator of cellular ATP levels, was
deemed the best indicator of cell viability for high throughput
screening. The rapid loss of ATP and membrane integrity, the
release of LDH and HMGB1, and the lack of caspase-3/7
activation all suggest necrosis is the mechanism of TcdB-mediated
death in HeLa cells.
Mutations in the autoprocessing domain active site and
the cleavage site result in TcdB proteins with impaired
autoprocessing activity in vitro and in cells
We next generated autoprocessing-deficient mutants that could
be used as negative controls in a secondary assay that would allow
us to select for molecules that inhibit the autoprocessing activity of
the toxin. Single amino acid point mutations were made in the
TcdB autoprocessing active site (C698S, C698A, H653A, and
D587N) and the cleavage site (L543A). Proteins were expressed in
the B. megaterium expression system and purified to homogeneity.
All mutants were tested for their in vitro autoprocessing activity
Author Summary
Clostridium difficile is an anaerobic spore-forming bacteri-
um that infects the human colon and causes diarrhea,
pseudomembranous colitis, and toxic megacolon. Most
people that develop disease symptoms have undergone
antibiotic treatment, which alters the normal gut flora and
allows C. difficile to flourish. C. difficile secretes two toxins,
TcdA and TcdB, that are responsible for the fluid secretion,
inflammation, and colonic tissue damage associated with
disease. The emergence of hypervirulent strains of C.
difficile that are linked to increased morbidity and mortality
highlights the need for new therapeutic strategies. One
strategy is to inhibit the function of the toxins, thereby
decreasing damage to the colon while the patient clears
the infection with antibiotics. Toxin function is thought to
depend on an autoprocessing event that releases a
catalytic ‘effector’ portion of the toxin into the host cell.
In the course of trying to identify small molecules that
would inhibit such a function, we found that TcdB induces
a rapid necrosis in epithelial cells that is not dependent on
autoprocessing. The physiological relevance of this obser-
vation is confirmed in colonic explants and suggests that
inhibiting TcdB autoprocessing will not prevent the
colonic tissue damage observed in C. difficile associated
diseases.
Toxin B Induced Damage of the Colonic Epithelium
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(Figure 2A). TcdB autoprocessing can be induced with the
addition of 1 uM InsP6, and the amount of processing increases
as the concentration of InsP6 increases. At all concentrations of
InsP6, TcdB C698S, TcdB C698A, and TcdB H653A were
completely inactive in autoprocessing, as detected by Coomassie-
stained SDS PAGE (Figure 2A) and densitometry (Figure 2B).
TcdB D587N and TcdB L543A had residual cleavage activity, but
were significantly cleavage-impaired. Cleavage of D587N was not
induced until 100 uM InsP6 was added, and the amount of
processed toxin was reduced.
Figure 1. TcdB induces necrosis in epithelial cells. A, TcdB does not induce caspase-3/7 activation in HeLa cells, as detected by a fluorescent
indicator, Apo-One. B, TcdB induces rapid death in HeLa cells, as detected by a luminescent indicator, CellTiterGlo. Caspase-3/7 activation and viability
values represent the average of three experiments in which each condition was tested in triplicate. The error bars indicate the standard deviation
between three experiments. C, HeLa cells were synchronized and incubated with or without TcdB for 2.5 hours at 37uC. A representative image
obtained by light microscopy indicates rounding in cells treated with 10 pM TcdB and a loss of membrane integrity in cells treated with 10 nM TcdB.
D, Extracellular LDH was detected in TcdB-treated HeLa cells after 2.5 hours using a luminescence-based indicator, Cytotox-Glo. Increased levels of
LDH release were apparent after 8 hours. LDH release values represent the average of three experiments in which three replicates were averaged.
Error bars indicate the standard deviation between the values obtained from the three experiments. E, HeLa cells were treated with a buffer control or
10 nM TcdB for 1 h and then fixed with 4% formaldehyde. Cells were stained with an antibody specific for HMGB1 and an Alexa Fluor 488 anti-mouse
antibody. The cells were visualized with a LSM510 Confocal microscope. The representative images show that HMGBI is released from the nucleus of
HeLa cells when treated with 10 nM TcdB and remains nuclear in the untreated cells.
doi:10.1371/journal.ppat.1003072.g001
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We next wanted to confirm that the mutants were also defective
for autoprocessing in the context of the cell. HeLa cells were
treated with wild-type TcdB or autoprocessing deficient TcdB
mutants for 50 min, lysed, and probed by Western blot using an
anti-TcdBGTD antibody. Free GTD was detected in cells treated
with wild-type TcdB but was not detected in cells intoxicated with
TcdB mutants (Figure 2C). The same lysates were probed with an
antibody specific for unglucosylated Rac1. Rac1 is glucosylated
even when the cells have been treated with autoprocessing
mutants. These data suggest that in cells treated with TcdB
autoprocessing mutants, the GTDs are being translocated into the
cytosol, but they remain tethered to the endosome where
glucosylation of Rac1 can still occur.
Autoprocessing mutants induce necrosis in cultured
epithelial cells
To test the hypothesis that small molecule inhibitors of TcdB
autoprocessing could be detected in a cell based screen, we
assessed cell viability in response to three of the TcdB autoproces-
sing mutants: TcdB C698S, TcdB C698A, and TcdB L543A.
HeLa cells were treated for 2.5 hours with multiple concentrations
of TcdB and the TcdB mutants, and viability was assessed using
CellTiterGlo. Unexpectedly, the autoprocessing deficient mutants
were found to induce cell death at concentrations comparable to
TcdB (Figure 3A). To test whether this response was unique to
HeLa cells, we performed similar experiments with Caco2 cells, an
epithelial cell line derived from human colon. As with the HeLa
cells, wild-type and autoprocessing deficient TcdB mutants
induced a decrease in cellular ATP at similar concentrations in
Caco2 cells (Figure 3B). Caspase-3/7 activation was not detected
in HeLa cells treated for 25 hours with autoprocessing deficient
TcdB mutants (Figure 3C), and the amount of LDH released in
HeLa cells treated with wild-type TcdB and the TcdB C698S,
C698A, and L543A autoprocessing mutants was equivalent
(Figure 3D). Finally, HeLa cells were treated with 10 nM wild-
type and mutant TcdB proteins in the presence of a live/dead cell
indicator and imaged every 10 minutes over a 2 hour time course.
A representative movie of what we observed is included in the
supplemental material (Video S1). The percentage of dead cells
quantified over six fields suggests that the kinetics of cell death are
identical for the four proteins (Figure S3). Collectively, these data
suggest autoprocessing is not required for TcdB-mediated necrosis
in epithelial cells.
TcdB induced necrosis is a glucosyltransferase
independent process
The idea that TcdB-induced necrosis did not require autopro-
teolytic release of the GTD suggested that the TcdB glucosyl-
transferase activity would also not be required for cytotoxicity. To
test this hypothesis, single amino acid point mutations were made
in the glucosyltransferase active site (D270N, D270A, Y284A,
W520A, and N384A) based on the crystal structure of the TcdB
GTD bound to UDP-glucose [38]. Proteins were expressed in the
Figure 2. Mutations in the autoprocessing domain active site
and the cleavage site result in TcdB proteins with impaired
autoprocessing activity in vitro and in cells. A, Autoprocessing was
induced in vitro by incubating wild-type TcdB and TcdB mutants with
multiple InsP6 concentrations and 1 mM DTT at 37uC. After 2 hours, the
proteins were subjected to SDS-PAGE and visualized with Coomassie
stain. A representative series of gels is shown from experiments
performed in triplicate. B, Three replicates of the experiments shown in
panel A were quantified by densitometry. Bands corresponding to TcdB
544–2366 were quantified and normalized to the band corresponding
to TcdB 1–2366 without InsP6. Error bars reflect the standard deviation
of the percent cleavage between three experiments. The data indicate
that wild-type TcdB autoproteolysis can be detected at concentrations
of 1 uM to 1 mM InsP6. By comparison, TcdB mutants C698S, C698A,
and H653A were completely inactive for autoprocessing at all InsP6
concentrations. The TcdB D587N and L543A had some residual activity,
but autoprocessing activity was impaired relative to wild-type. C, GTDs
of autoprocessing mutants are not released in cells. HeLa cells were
synchronized for 30 minutes at 4uC, then intoxicated with 10 nM toxin.
Intoxicated cells were incubated at 4uC for an hour before being moved
to 37uC. Cells were harvested after 50 minutes, and cell lysates were
prepared for SDS PAGE and Western blot. The blot was probed with
antibodies against the TcdB GTD, unglucosylated Rac1, total Rac1, and
GAPDH. While release of the GTD in cells intoxicated with wild-type
TcdB was detected, the free GTD was not detected in cells treated with
autoprocessing deficient mutants. The absence of signal with an
antibody that recognizes unglucosylated Rac1 suggests that the
autoprocessing mutants are still able to modify Rac1 in cells.
doi:10.1371/journal.ppat.1003072.g002
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B. megaterium expression system and purified to homogeneity. All
mutants were tested for their in vitro glucosyltransferase activity in
the presence of purified Rac1 and UDP[14C]glucose, and all were
impaired relative to wild-type (Figure 4A). Of the five mutants, the
TcdB D270N mutant showed the greatest defect in in vitro
glucosyltransfer, with residual activity only evident in the highest
concentrations of enzyme and substrate (Figure 4B). Even with
differences in the amount of residual activity, all five mutants were
defective in the modification of Rac1 in cells (Figure 4C).
Furthermore, all 5 mutants were capable of inducing a cytotoxic
effect similar to that of wild-type TcdB when applied to HeLa cells
(Figure 4D) and Caco-2 cells (data not shown). We interpret these
data to mean that the TcdB cytotoxic effect does not require the
glucosyltransferase activity of the toxin.
The low concentration cytopathic effect is functionally
distinct from the high concentration cytotoxic effect
The observation that TcdB autoprocessing mutants were able to
glucosylate Rac1 in cells (Figure 2C) suggested that they would
induce rearrangements in the actin cytoskeleton that result in the
cytopathic ‘rounding’ phenotype. To investigate this, HeLa cells
were treated with multiple concentrations of wild-type and mutant
TcdB proteins and imaged every 10 minutes over a 2 hour time
course. The percentage of round cells was quantified over six fields
for each concentration and time point. At a 10 pM concentration,
we observed similar rounding kinetics for TcdB and the three
TcdB autoprocessing-deficient mutants (Figure 5A). Differences in
the kinetics of rounding began to appear at a concentration of
100 fM (Figure 5B) but were not fully evident until the
concentration of toxins was dropped to 1 fM (Figure 5C). The
full dataset collected at concentrations spanning 8 orders of
magnitude and a movie of what we observed with 10 fM wild-type
TcdB is included in the supplemental material (Figure S4 and
Video S2). While not required for cytotoxicity, autoprocessing and
GTD release appear to be important for cytopathic processes that
occur at very low concentrations. In HeLa cells, we see that at
concentrations where cytopathic effects can be observed (1 fM–
10 pM, Figure 5), the cells are not dead (Figure 3A). These data
provide a clear distinction between the cytotoxic and cytopathic
effects induced by TcdB.
Figure 3. Autoprocessing mutants induce necrosis in epithelial cells. A, Toxins were applied to HeLa cells at concentrations ranging from
0.1 pM to 100 nM, and viability was measured after 2.5 hours with CellTiterGlo. B, Toxins were applied to Caco2 cells at concentrations ranging from
0.1 pM to 100 nM, and viability was measured after 18 hours with CellTiterGlo. Percent viability was determined by normalizing the signal from
treated cells to the signal from untreated cells. C, Autoprocessing mutants did not induce caspase-3/7 activation after 25 hours. D, Comparable levels
of extracellular LDH were detected after 8 hours in HeLa cells treated with wild-type TcdB and TcdB autoprocessing mutants. In each panel, the
values represent the average of three experiments in which three replicates were averaged. Error bars indicate the standard deviation between the
values obtained from the three experiments.
doi:10.1371/journal.ppat.1003072.g003
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TcdB and TcdB C698A cause epithelial damage in porcine
colonic explants
The distinction between cytopathic and cytotoxic events in cell
culture led us to question if either event might correlate with
disease pathology. Since the formation of necrotic lesions in the
colon is a hallmark of CDAD pathology, we sought to determine
the concentration of toxin required to induce these effects and
whether autoprocessing was required. Porcine colonic explants
were incubated with multiple concentrations of toxin for 5 hours.
The tissue was fixed with formalin, embedded in paraffin, and
sections were stained with H&E (Figure 6A). The slides were
scored in a blinded fashion and given a score (0–3) to reflect the
level of epithelial damage (Figure 6B). Damage ranged from a
mostly intact surface epithelium to mucosal loss of 50% or greater
in the depth of colonic crypts. The scores indicated a loss of surface
epithelium in tissue treated for 5 hours with 10 nM TcdB and
TcdB C698A. There was little damage in tissues treated with a
buffer control or in tissues treated with wild-type TcdB and TcdB
C698A at a concentration of 10 pM. Statistical analysis by two-
way ANOVA revealed a significant difference in scores for tissues
treated with the toxins over the range of concentrations (p,0.001),
while there was no statistical difference between tissues treated
with wild-type TcdB and TcdB C698A. A subsequent Bonferroni’s
test revealed that scores given to tissue treated with 10 nM TcdB
and 10 nM TcdB C698A were significantly different from scores
given to tissue treated with 10 pM TcdB and 10 pM TcdB C698A
(p,0.001). The tissues were stained with an anti-pan cytokeratin
antibody to confirm the keratin positive cells at the luminal surface
of the colon were disrupted (Figure 6C) and an anti-activated
caspase-3 antibody to confirm that the toxin treatment did not
induce an apoptotic response (Figure 6D). The data reveal a
correlation between the concentration of toxin required to kill
epithelial cells in culture with the concentration required to disrupt
epithelial integrity in colonic tissue and indicate that autoproces-
sing is not required for tissue damage.
Discussion
TcdB is a multi-functional protein with a central role in CDAD
pathogenesis. Our goal at the outset of this study was to conduct a
screen for small molecule inhibitors that could aid in the dissection
of the TcdB mechanism and the generation of new leads for
therapeutic intervention. Our strategy was to combine a cell-based
phenotypic screen with target-specific secondary assays. In the
course of setting up our screening assays, we made two unexpected
observations that warranted further investigation.
First, in contrast to a previous report [18], TcdB did not trigger
the induction of apoptosis in cultured epithelial cells as measured
by caspase-3/7 activation (Figure 1A, S1). Since there was an
overlap in the cells, concentration of toxin, and timepoints used for
analysis, we are left to speculate that the difference stems from
advances in the detection reagent. The newer reagent for detecting
caspase-3/7 activation allows one to directly quantitate the relative
quantity of activated caspase-3/7 as opposed to the overall rate of
caspase activity.
While TcdB-treatment did not induce the activation of caspase-
3/7, the rapid ATP depletion observed in both HeLa (Figure 1B,
3A, S2A) and Caco2 (Figure 3B) cells suggested that the
mechanism of TcdB-induced cell death was likely necrosis. The
observed loss of membrane integrity (Figure 1C), rapid LDH
(Figure 1D, S2B), and HMGB1 release (Figure 1E) support this
conclusion.
We next questioned whether a cell-based assay for small
molecule inhibitors of TcdB-induced necrosis would allow us to
detect molecules that interfered with autoprocessing. We were
particularly interested in targeting the autoprocessing activity of
the toxin since, in theory, one could identify molecules that either
activate (e.g. InsP6) or inhibit the function of the cysteine protease
domain. We generated five TcdB point mutants in which key
residues of the cysteine protease active site or cleavage site were
Figure 4. TcdB glucosyltransferase mutants cause epithelial
cell death. A, TcdB and TcdB glucosyltransferase domain mutants
(100 nM) were tested for their capacity to glucosylate purified Rac1
(2 uM) in the presence of 20 mM UDP-[14C]-glucose over the course of
1 h. The proteins were resolved by SDS-PAGE, and the gels were
analyzed by phosphorimaging. B, TcdB D270N was tested with higher
concentrations of both toxin and UDP-[14C]-glucose. Only at the highest
concentrations of both toxin and UDP-[14C]-glucose is residual activity
apparent. C, The TcdB glucosyltransferase mutants are impaired in their
glucosyltransferase activities in HeLa cells, as determined by Western
and an antibody specific for unglucosylated Rac1. D, Wild-type TcdB
and the TcdB glucosyltransferase mutants induced comparable levels of
HeLa cell death, as determined by CellTiterGlo, after 2.5 h of treatment.
Percent viability was determined by normalizing the signal from treated
cells to the signal from untreated cells. Values reflect the average signal
from three experiments in which each condition was tested in triplicate.
Error bars correspond to the standard deviation in the percent viability
from the three experiments.
doi:10.1371/journal.ppat.1003072.g004
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mutated. Three of these mutations, C698S, C698A, and L543A,
rendered TcdB non-functional for InsP6-induced autoprocessing
in an in vitro assay, even when InsP6 was added at a 1 mM
concentration (Figure 2A, 2B). The mutants were also defective for
autoprocessing in the context of cells since free GTD could be
detected in cells treated with wild-type TcdB but not in cells
treated with the autoprocessing mutants (Figure 2C). While we
cannot rule out the possibility of an alternate cleavage mechanism
that results in a quantity of free GTD that is less than the detection
limit of the assay, the free GTD concentration generated from
such a mechanism would be too small to account for the identical
cytotoxicity profiles observed in Figures 3A and 3B.
The unexpected observation that cytotoxicity does not require
autoproteolytic release of the GTD led us to directly test whether
the glucosyltransferase activity of the toxin was required (Figure 4).
We generated five single amino acid point mutants of TcdB that
differed in their residual glucosyltransferase activities in vitro
(Figure 4A, 4B). Despite the different enzyme activity levels, all
were significantly impaired relative to wild-type TcdB in their
capacity to modify Rac1 in cells (Figure 4C), and all were
comparable to wild-type TcdB in their cytotoxic effects
(Figure 4D). These data are consistent with the observation that
autoprocessing is not required and suggest that the cytotoxic
response to TcdB is triggered by an event upstream of GTD
release.
While not required for cytotoxicity, autoprocessing and GTD
release are important for cytopathic processes that occur at low
concentrations [29,32,34,36,37]. Our data are consistent with
these previous reports and indicate differences in rounding kinetics
emerging at concentrations of 100 fM (Figure 5C and SF4). While
our Western experiment indicated TcdB autoprocessing mutants
were still able to modify Rac1 in cells (Figure 2C), a similar
observation has been made for a non-cleavable form of TcdA and
is thought to reflect continuous vesicle trafficking and an exchange
of membranous compartments that allow the uncleaved toxin to
come into contact with the membrane-bound GTPases [39]. This
capacity to modify Rac1 while still tethered to the endosomal
membrane presumably accounts for the similar rounding kinetics
that we observed when the TcdB autoprocessing mutants were
applied to HeLa cells at concentrations of 1 pM and higher
(Figure 5A, S4).
The concentrations of TcdB needed to induce cytopathic effects
(#1 fM, Figure S4) are significantly lower than what is required to
induce the cytotoxic effect (1 nM, Figure 3). At a concentration of
10 pM TcdB, the cells are clearly round (Figure 5A) but not dead
(Figure 3). The distinction between cytopathic and cytotoxic events
Figure 5. TcdB and TcdB autoprocessing mutants cause cell rounding with concentration dependent kinetics. HeLa cells were treated
with multiple concentrations of wild-type and mutant TcdB proteins and imaged every 10 minutes over a 2 hour time course. The percentage of
round cells was quantified over six fields for each concentration and time point. The kinetics of rounding induced by TcdB and the TcdB
autoprocessing mutants is shown at concentrations of A, 10 pM. B, 100 fM and C, 1 fM. D, Representative images of cells treated with 1 fM TcdB and
TcdB autoprocessing mutants for 50 minutes. Green cells are alive; red cells are dead. Images were collected with an Opera High-Throughput
Confocal Screening Microscope in an environment-controlled chamber at 37uC, 5% CO2. Round cells were defined as having an area less than
500 um2 and a width-to-length ratio of less than 0.4. Analysis was performed using Columbus Analysis software.
doi:10.1371/journal.ppat.1003072.g005
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in cell culture raises the question of whether either process
correlates with mechanisms of pathology observed in the host. To
address this question, we decided to test what concentration of
toxin was required to induce epithelial cell damage in colonic
tissue explants. Visual assessment of H&E stained colonic tissue
integrity in a blinded fashion indicated damage with treatments of
10 nM TcdB but not with 10 pM TcdB (Figure 6). Similar
observations were made with the TcdB C698A mutant suggesting
that the damage that occurs to colonic tissue in response to TcdB
does not depend on the autoprocessing activity. Pan-cytokeratin
staining confirmed that the cells on the luminal surface of the
tissue remained intact in the presence of 10 pM TcdB or TcdB
C698A but were being disrupted in samples treated with 10 nM
TcdB, 10 nM TcdB C698A, or 100 uM staurosporine. The
staurosporine control revealed strong caspase-3 activation into the
crypts (Figure 6D). The untreated control tissue demonstrated a
Figure 6. TcdB and TcdB C698A cause epithelial damage in porcine colonic explants. Porcine colonic explants were treated with 1 mM
DTT to remove the mucus layer, washed with PBS, and incubated with toxin at 37uC for 5 hours. A, Tissue sections were stained with H&E. B, The H&E
slides were scored in a blinded fashion using a semi-quantitative injury scale: 0- no damage; 1-superficial damage, damage limited to intact surface
epithelial cells; 2-loss of up to 50% of surface epithelial cells or gland length, crypts intact; 3-loss of over 50% of surface epithelial cells and damage in
greater than 50% of gland length. An injury score was calculated as the mean score for sections analyzed seven times by six individuals. Statistical
analysis was performed using a two-way ANOVA and post-hoc tests. These analyses revealed a significant difference in the scores given to tissues
treated with the toxins over the range of concentrations (p,0.001), while there was no statistical difference between tissues treated with TcdB and
TcdB C698A. A subsequent Bonferroni’s test revealed that scores given to tissue treated with 10 nM TcdB and 10 nM TcdB C698A were significantly
different from scores given to tissue treated with 10 pM TcdB or 10 pM TcdB C698A (p,0.001). Error bars correspond to the standard deviation
between the seven scores. C, The sections were also stained with an anti-pan keratin and D, anti-active caspase-3 antibody. Representative images of
H&E, pan-cytokeratin, and active caspase-3 staining (white – pan-cytokeratin/active caspase-3, green – DAPI) show significant damage to the
epithelium of the colon at concentrations of TcdB and TcdB C698A that kill cells (10 nM). At concentrations that induce rounding but not death in
cultured cells (10 pM), there was no significant damage to the tissue surface cells. Caspase-3 activation was not detected at levels above background
in any of the TcdB-treated tissues.
doi:10.1371/journal.ppat.1003072.g006
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low level of caspase-3 activation in the cells on the luminal surface
and strong activation in single cells coming off the surface of the
tissue. Tissues treated with 10 pM TcdB and TcdB C698A
showed caspase-3 activation levels similar to those of the untreated
tissue. Tissue treated with 10 nM TcdB or TcdB C698A
demonstrated even lower levels of caspase-3 activation, presum-
ably because the cells on the luminal surface have been shed.
Unlike the untreated, staurosporine-treated, and 10 pM TcdB-
treated tissues, caspase-3 activation was generally not observed in
the cells that were in the process of being shed in tissues treated
with 10 nM TcdB or TcdB C698A (Figure 6D). This suggests that
tissue damage is not only independent of autoprocessing activity,
but also not likely due to apoptosis.
The phenotypic differences with concentration led us to wonder
what concentration of toxin is present in the colons of individuals
experiencing the symptoms of CDAD. We found only one
published report, where TcdB was quantitated using a real-time
cell analysis system [40]. In this report, the TcdB concentrations in
stool samples from 10 patients experiencing mild to severe
symptoms of CDAD ranged from 4.9 pM to 413 pM with a
mean concentration of 146 pM. Presumably, the concentration of
TcdB would be much higher at the colonic epithelium prior to
dilution by diarrhea. Of note, the average TcdB concentration in
samples from 9 individuals who were not experiencing CDAD
symptoms was 1 pM, with a range of 0.1 pM to 3.3 pM. This
analysis suggests that the cytotoxic effects observed in cells and
tissues treated with 1 to 10 nM TcdB are better correlated with
pathology than the cytopathic effects that are induced at 1 fM
concentrations.
Our data suggest that inhibiting TcdB autoprocessing will not
prevent the colonic tissue damage observed in C. difficile associated
diseases. However, while the colonic epithelium is the primary
barrier separating C. difficile from the host, it is possible that the
autoprocessing function of TcdB is important in another setting
relevant to pathogenesis. For example, the colonic explant model
used in this study does not account for the impact of the toxins on
inflammation or the potential impact of an anaerobic environ-
ment. Evaluating the effect of autoprocessing- and glucosyltrans-
ferase-deficient toxins in an animal model of C. difficile infection
therefore represents a priority for future studies. In addition, it will
be important to define the mechanism of TcdB-mediated necrosis
in cells and tissue. Relevant comparisons may come from the study
of other toxins. For example, the Bordetella pertussis adenylate
cyclase (AC) toxin is known to have multiple mechanisms that
contribute to cytotoxicity [41]. Identifying the autoprocessing- and
glucosyltransferase-dependent and –independent aspects of TcdB-
mediated pathology represents an exciting path for future study.
Materials and Methods
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Animal
husbandry and experimental procedures related to the porcine
colonic explants were performed in accordance with the
Vanderbilt University Institutional Animal Care and Use Com-
mittee (IACUC) policy. Discarded colon tissues were obtained
from pigs following euthanization at the end of IACUC-approved
animal use protocols. Animal husbandry and experimental
procedures related to the generation of the anti-TcdBGTD
monoclonal antibody were performed in accordance with the
Washington University Animal Studies Committee policy, ap-
proval number 20100113.
Expression of recombinant proteins
Single amino acid point mutations were made in the TcdB
autoprocessing active site (C698S, C698A, H653A, and D587N),
the cleavage site (L543A), and the glucosyltransferase domain
(D270N, D270A, Y284A, N384A, and W520A) using the
QuickChange mutagenesis protocol (Stratagene). The template
for mutagenesis and clone for the production of wild-type TcdB
was a B. megaterium expression vector encoding the strain 10643 of
TcdB [42]. A similar clone was used for expression of recombinant
TcdA [42]. Plasmids for expressing TcdA, TcdB, and TcdB point
mutants were transformed into B. megaterium according to the
manufacturer’s instructions (MoBiTec, Go¨ttingen, Germany). 1 L
of LB was inoculated with 35 mL overnight culture and 10 mg/L
tetracycline and grown at 37uC and 230 rpm. At an OD600 of 0.3,
expression was induced with 5 g of D-xylose. Cells were harvested
after 4 h by centrifugation and resuspended in 20 mM Tris,
pH 8.0, 500 mM NaCl and protease inhibitors. Cells were lysed
by French press, and lysates were centrifuged at 48,000 g for
25 min. The proteins were purified by Ni-affinity chromatogra-
phy, Q-sepharose anion exchange chromatography, and gel
filtration chromatography in 20 mM HEPES, pH 6.9, 50 mM
NaCl.
Protein purification from C. difficile
Proteins were expressed and purified as previously described
[1].
Cell death assays
HeLa and Caco2 cells (cultured in DMEM, 10% FBS, 5% CO2
and MEM, 10% FBS, 5% CO2, respectively) were seeded in a
black 384-well plate at a concentration of 3,000 or 1,000 cells/
well, respectively. HeLa cells were intoxicated the next day, and
Caco2 cells were intoxicated 36 h later. After intoxication, the
cells were incubated at 37uC, 5% CO2 for either 2.5 h (HeLa) or
18 h (Caco2). The amount of ATP (cell viability) was assessed with
a luminescence-based indicator, CellTiterGlo (Promega). LDH
release was assessed with a luminescence-based indicator,
CytoToxGlo (Promega). Caspase-3/7 activation was determined
using a fluorescent indicator, Apo-One (Promega). Staurosporine
(Sigma, 1 mM) was used as a positive control for caspase-3/7
activation. Plates were read in a Biotek Synergy 4 plate reader.
HMGB1 release
HeLa cells were seeded into a tissue culture treated chamber
slide at 26104 cells per well and incubated overnight. Cells were
synchronized at 4uC and intoxicated with 10 nM TcdB for 1 h.
Cells were then shifted to 37uC for 1 h. Media was removed from
the cells, and the cells were washed with PBS. They were fixed
with 4% paraformaldehyde at room temperature for 10 minutes
and quenched with 1 mM glycine. Cells were permeated with
0.2% Triton X-100 in PBS for 5 minutes, washed in PBS, and
blocked for 30 minutes in PBS, 2% BSA, 0.1% Tween 20. Cells
were stained with a monoclonal antibody against HMGBI
(Abcam, ab77302), and an Alexa Fluor 488 anti-mouse antibody
(Invitrogen, A11001). Cells were visualized with an LSM 510
Confocal microscope.
In vitro cleavage assay
1 uL InsP6 stock solution (1006) or buffer was added to
200 nM TcdB or TcdB autoprocessing mutant and incubated for
2 h at 37uC. The reactions were stopped with the addition of
loading buffer and boiling and analyzed by Coomassie stained
SDS PAGE.
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Anti-TcdBGTD antibody generation
Genomic DNA of C. difficile clinical isolate 630 was obtained
from American Type Culture Collection, and the region encoding
residues 1 to 549 of TcdB, which is known to encode the substrate
binding and enzymatic domains of the toxin, was amplified in
frame with a carboxy-terminal (His)6-tag using upstream prim-
er:59- CCGGATGTACAGTTGAGGGGGTAAAATGAGTTT-
AGTTAATAGAAAACAGTTAG -39 and downstream primer
59- GGTCCTCAATGATGGTGATGGTGATGAAGATTAT-
CATCTTCACCAAGAGAACC -39. The resulting product was
cloned into plasmid pcDNA3.1 (Invitrogen, Carlsbad CA) and
sequenced to ensure fidelity of the amplified product. The gene
was then released with restriction enzymes BsrG1 and AgeI and
cloned into similarly digested vector pHIS1525 (MoBiTec),
placing the gene under control of a xylose-inducible promoter.
Recombinant protein was expressed in B. megaterium and purified
by sequential nickel affinity and gel filtration chromatography.
Two mice were immunized bi-weekly by intraperitoneal injection
with 100 mg purified TcdB-GTD. Three days after the third
vaccination, splenocytes were harvested and fused to
P3X63Ag8.6.5.3 myeloma cells using polyethylene glycol 1500
[43]. Hybridomas producing anti-TcdB-GTD MAbs were iden-
tified by ELISA, subcloned by limiting dilution, and purified by
protein G immunoaffinity chromatography.
Cell based cleavage assay
HeLa cells were synchronized by cooling to 4uC and then
intoxicated with 10 nM TcdB, autoprocessing mutant, or buffer.
The cells were returned to 4uC for 1 h, and then shifted to 37uC
for 50 min. The cells were harvested and lysed, samples were
boiled, and proteins were separated by SDS PAGE. Samples were
analyzed by Western with primary antibodies specific for the TcdB
GTD, unglucosylated Rac1 (BD, 610650), total Rac1 (Millipore,
clone 23A8), and GAPDH (Santa Cruz Biotechnology, sc-25778).
Binding of an anti-mouse, HRP-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories, 115-035-174) was de-
tected with a LumiGLO kit (Cell Signaling) according to
manufacturer’s instructions.
In vitro glucosyltransferase assay
Unless otherwise noted, 100 nM TcdB or TcdB glucosyltrans-
ferase mutants and 2 uM Rac1 were mixed with 20 mM UDP-
[14C]glucose (250 mCi/mmol, Perkin Elmer) in a total reaction
volume of 10 uL. The buffer contained 50 mM HEPES pH 7.5,
100 mM KCl, 1 mM MnCl2, 2 mM MgCl2, and 0.1 mg/mL
BSA. Reactions were incubated at 37uC for 1 h and stopped with
the addition of loading buffer and boiling. Proteins were separated
by SDS PAGE, and glucosylation of Rac1 was detected by
phosphorimaging.
Kinetic assays of cytotoxic and cytopathic events
HeLa cells were seeded in a black 96-well imaging plate
(PerkinElmer) and incubated overnight. Cells were pretreated with
live/dead cell imaging dyes (Molecular Probes, R37601) and then
treated with multiple concentrations of wild-type and mutant
TcdB proteins. Cells were imaged in an environment-controlled
chamber (37uC, 5% CO2) every 10 minutes over a 2 hour
timecourse using an Opera High-Throughput Confocal Screening
Microscope and Peltier-cooled, confocal CCD cameras. The
percentage of dead cells and round cells was quantified over six
fields for each concentration and time point using the Columbus
Analysis software. Dead cells were defined as red cells with an
intensity greater than 450 relative units, and round cells were
defined as having an area less than 500 um2 and a width-to-length
ratio of less than 0.4.
Porcine colonic explants
Colonic tissue was harvested from purpose-bred 25–35 kg, male
or female, York-Landrace crossbred pigs. Following an overnight
fast and immediately after euthanasia, a midline incision was
performed and 15 cm of distal colon proximal to the rectum was
excised and placed in PBS. The colon was opened, the luminal
side was washed 365 min in 1 mM DTT to remove the mucus,
and 365 min in PBS prior to dissection. Individual tissue sections
were placed in wells of a 24-well plate. A nutrient buffer [44]
containing (mM/liter): 122.0 NaCl, 2.0 CaCl2, 1.3 MgSO4, 5.0
KCl, 20.0 glucose, 25.0 NaHCO3 (pH 7.5) was pre-conditioned
with HeLa cells overnight at 37uC and used to dilute the toxins.
Explants were treated with wild-type TcdB, mutant TcdB,
staurosporine (100 uM, Enzo Life Sciences, ALX-380-014-C250)
or nutrient buffer for 5 hours at 37uC. The tissues were fixed with
formalin for 56 h, washed in PBS, and transferred to cassettes.
The tissue blocks were then embedded in paraffin, and 4 mm
sections were cut and stained with hematoxylin and eosin (H&E)
by the Vanderbilt University Translational Pathology Shared
Resource core. Stained sections were coded and evaluated by six
individuals, using a semi-quantitative injury scale: 0- no damage;
1-superficial damage, damage limited to intact surface epithelial
cells; 2-loss of up to 50% of surface epithelial cells or gland length,
crypts intact; 3-loss of over 50% of surface epithelial cells and
damage in greater than 50% of gland length. An injury score was
calculated as the mean score for sections evaluated seven times by
six individuals. Statistical analysis was performed using a two-way
ANOVA and Bonferroni’s test. For keratin and caspase staining,
sections were de-paraffinized with Histo-clear (National Diagnos-
tics) and antigens were retrieved by citric acid. The sections were
blocked with Serum-free protein block (Dako), stained with a
rabbit anti-pan cytokeratin or anti-active caspase-3 antibody
(Santa Cruz Biotechnology, sc-15367; Abcam, ab13847), and
diluted in Dako’s antigen diluent with background reducing
components overnight at 4uC. The sections were washed with PBS
and incubated for 1 hr at RT with an AlexaFluor 546 donkey anti-
rabbit antibody (Invitrogen A10040). The sections were washed
with PBS and mounted with Prolong Gold with DAPI (Invitrogen).
H&E, pan-cytokeratin, and caspase-3 stained sections were
imaged using an Ariol SL-50 (Epithelial Biology Center Imaging
Core).
Supporting Information
Figure S1 TcdA activates caspase-3/7 while both re-
combinant and native TcdB do not. A, TcdB does not induce
caspase-3/7 activation in HeLa cells, as detected by a fluorescent
indicator, Apo-One, at 24 or 48 h. TcdA, however, does induce
caspase-3/7 activation at a concentration of 100 nM at 24 h and
10 and 100 nM at 48 h. B, TcdB purified from C. difficile
supernatant looks similar to TcdB purified from B. megaterium in
that neither induce caspase-3/7 activation. Values represent the
average of 3 independent experiments in which each condition
was tested in triplicate. Error bars represent the standard deviation
of the average of the three independent experiments.
(TIF)
Figure S2 TcdB is more cytotoxic than TcdA, and the
effects of native and recombinant TcdB on LDH release
are similar. A, TcdB induces significant HeLa cell death, as
detected by CellTiterGlo, in 24 h at concentrations of 1, 10, and
100 nM. At 48 h, a loss of cell viability was observed at lower
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concentrations in a dose-independent fashion. TcdA induces
significant cell death at 24 h and 48 h at a concentration of
100 nM. B, TcdB purified from C. difficile and B. megaterium induce
release of LDH starting at 2.5 h, with increased levels apparent
after 8 h of treatment. Values represent the average of 3
independent experiments in which each condition was tested in
triplicate. Error bars represent the standard deviation of the three
independent experiments.
(TIF)
Figure S3 TcdB and TcdB autoprocessing mutants have
the same cytotoxicity kinetics. A, TcdB, TcdB C698S, TcdB
C698A, and TcdB L543A at 10 nM induce HeLa cell death at
similar rates, as detected by Live/Dead Cell Imaging dyes. Values
represent the number of red (dead) cells per total number of cells
(red+green) over six image fields and were calculated using
Columbus Analysis Software. Dead cells were defined as having a
red intensity greater than 450 relative units. B, Representative
pictures of TcdB treated cells at 0 and 120 minutes. Images were
taken using an Opera High-Throughput Confocal Screening
Microscope.
(TIF)
Figure S4 TcdB and TcdB autoprocessing mutants have
different cytopathic kinetics at 1 fM. HeLa cells were
treated with multiple concentrations of wild-type and mutant
TcdB proteins and imaged every 10 minutes over a 2 hour time
course. The percentage of round cells was quantified over six fields
for each concentration and time point. Percent rounded cells
induced by TcdB and autoprocessing mutants is shown at
concentrations of A, 10 nM, B, 1 nM, C, 100 pM, D, 10 pM, E,
1 pM, F, 100 fM, G, 10 fM, and H, 1 fM. Differences in the
rounding kinetics between TcdB and autoprocessing mutants
begin to appear at a concentration of 100 fM and are clearly
distinct at 1 fM. Images were collected with an Opera High-
Throughput Confocal Screening Microscope in an environment-
controlled chamber at 37uC, 5% CO2. Round cells were defined
as having an area less than 500 um2 and a width-to-length ratio
greater than 0.4. Analysis was performed using Columbus Analysis
software.
(TIF)
Video S1 Cytotoxicity induced by TcdB. HeLa cells were
treated with 10 nM TcdB and imaged every 10 minutes over a
2 hour time course. The 13 frames, reported in SF3, are compiled
to show how cells change with time. Green cells are alive; red cells
are dead.
(MP4)
Video S2 Cytopathy induced by TcdB. HeLa cells were
treated with 10 fM TcdB and imaged every 10 minutes over a
2 hour time course. The 13 frames, reported in SF4, are compiled
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